$515.67-22.48 (-4.18%)
Axon Enterprise, Inc.
Axon Enterprise, Inc. in the Industrials sector is trading at $515.67 with a market capitalization of $38.8B. Wall Street consensus targets $693.40 (19 analysts), implying a +34.5% move over the next 12 months. The stock is currently 35% below its 52-week high of $792.16, remaining 2.0% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $904.39M↑ | $807.35M↑ | $796.72M↑ | $710.64M↑ | $668.54M |
| Gross Profit | $546.45M↑ | $477.29M↑ | $461.30M↑ | $427.35M↑ | $403.74M |
| Operating Income | $46.78M↑ | $29.24M↑ | -$50.12M↓ | -$2.13M↓ | -$1.04M |
| Net Income | $29.43M↓ | $169.31M↑ | $2.75M↑ | -$2.19M↓ | $36.12M |
Axon Enterprise, Inc. provides public safety technology solutions in the United States and internationally. The company operates in two segments, Software and Services, and Connected Devices. The Software and Services segment develops, manufactures, ...

Axon (AXON) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

AXON's Connected Devices revenues surge 34.6%, fueled by TASER 10, counter-drone equipment and strong international bookings.

Isner retains direct holdings of 296,973 shares valued at $168.25 million, with the sale executed under a pre-scheduled Rule 10b5-1 trading plan established in June 2026.

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Axon (NASDAQ:AXON) and its peers.
Academic risk and quality models computed from AXON's own filings and price history, not from analyst opinion.
Mixed: 5 of 9 fundamental-health tests pass, so profitability and balance-sheet trends disagree.
Altman Z above the 2.99 safe threshold, so the model puts bankruptcy risk in its lowest band.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
GARCH(1,1) 30-day annualised forecast, below the current 64.2% reading.
Fama-French 5-factor market beta. The five factors explain 20% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-06-26.